The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1810631 in Healthy Male Subjects (an Open-label, Two-period, Fixed-sequence Trial)
Latest Information Update: 18 Oct 2024
Price :
$35 *
At a glance
- Drugs Itraconazole (Primary) ; Zongertinib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 12 Jun 2023 Status changed from active, no longer recruiting to completed.
- 22 May 2023 Status changed from recruiting to active, no longer recruiting.
- 03 May 2023 New trial record